Filing metadata

Accession number
0001209191-17-056550
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Oct 10, 2017
Reporting period
Oct 06, 2017
Description
Insider transaction

Explore SEC Filings Hub